Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease
- 18 December 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 258 (2), 81-84
- https://doi.org/10.1016/s0304-3940(98)00856-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampusBrain Research, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)Neurology, 1996
- The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous systemNeuron, 1995
- Degeneration of the intrahippocampal routes of the perforant and alvear pathways in senile dementia of Alzheimer typeNeuroscience Letters, 1995
- Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body diseaseActa Neuropathologica, 1994
- Diffuse lewy body disease in JapanZeitschrift für Neurologie, 1990
- Lewy bodies are ubiquitinatedActa Neuropathologica, 1988
- Perforant pathway changes and the memory impairment of Alzheimer's diseaseAnnals of Neurology, 1986
- PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASEJournal of Neuropathology and Experimental Neurology, 1965